1. CURRICULUM VITAE
NAME Jeanne Susan Mandelblatt, MD,
BUSINESS ADDRESS Cancer Control Program
Lombardi Comprehensive Cancer Ctr, Dept of Oncology
Georgetown University School of Medicine
3300 Whitehaven Ave - Suite 4100
Washington, D.C. 20007
Phone (202) 687-0812 / Fax (202) 687-0305
CITIZENSHIP United States
LICENSURE DC, NYS
1979 American Board of Family Practice (re-certified 1998; 2005)
1990 Geriatrics, American Boards of Internal Medicine and Family Practice
1968-72 University of Southern California, Los Angeles. California, Bachelor of Arts and
Science, Psychology and Biology
1972-76 Columbia University College of Physicians and Surgeons, NYC, MD.
1976-79 Montefiore Medical Center, Bronx, NY, Residency Program in Social Medicine,
Department of Family Medicine
1984-87 Mount Sinai School of Medicine, NY, NY, Department of Community Medicine,
Preventive Medicine Residency, board eligible
1987-89 Montefiore Medical Center, Bronx, NY, Dept of Medicine, Geriatrics Fellowship
1990-91 Columbia University School of Public Health, Division of Epidemiology, NY, NY,
1994-present Columbia University, Graduate School of Arts and Sciences, School of Public
Health, NY, NY, ABD, Cancer Epidemiology
2. PROFESSIONAL EXPERIENCE
1981-86 Clinical Instructor, Department of Medicine, Mount Sinai School of Medicine,
1986-87 Assistant Clinical Professor, Department of Medicine, Mount Sinai School of
Medicine, NY, NY
1987-89 Assistant Professor, Department of Epidemiology and Social Medicine,
Albert Einstein School of Medicine. Bronx, NY
1989-93 Assistant Professor and Member, Department of Epidemiology and Biostatistics,
Memorial Sloan-Kettering Cancer Center, NY, NY
1989-93 Assistant Professor and Member, Department of Medicine, Cornell University
School of Medicine, NY, NY
1993-94 Associate Professor and Member, Department of Epidemiology and Biostatistics,
Memorial Sloan-Kettering Cancer Center, NY, NY
1993-94 Associate Professor, Department of Medicine, Cornell University Medical School,
1994-2001 Associate Professor, Department of Medicine, Georgetown University School of
Medicine, Washington, DC
2001-present Professor, Department of Medicine, Georgetown University School of Medicine,
1994-present Director, Cancer and Aging Research, Cancer Control Program, Lombardi
Comprehensive Cancer Center, Washington, DC
1996-2001 Director, Cancer Clinical and Economic Outcomes Core, Lombardi Cancer Center,
1999-00 Co-Director, Cancer Control Program, Lombardi Comprehensive Cancer Center,
1999-2000 Acting Director, Division of Behavioral and Health Outcomes Research,
Department of Oncology, GUMC, Washington, DC
1999-2001 Associate Professor, Department of Oncology, Georgetown School of Medicine,
2001-present Professor, Department of Oncology, Georgetown School of Medicine,
2000-2008 Director, Cancer Control Program, Lombardi Comprehensive Cancer Center,
3. Washington, DC
2000-2008 Director, Division of Health Behaviors and Outcomes, Department of Oncology,
GUMC, Washington, DC
2008-present Associate Director for Population Sciences, Lombardi Comprehensive Cancer
Center, Washington, DC
AWARDS AND HONORS
1976 Magna Cum Laude, University of Southern California
1989 Academic Award, National Institute on Aging
2006 Komen Foundation Professor of Survivorship Award
2002, 2007 Senior Cancer Control Scientist Award, National Cancer Institute
1979-present American Academy of Family Physicians
1985-1994; 2007-present Society for General Internal Medicine
1986-present American Public Health Association
1989-present American Society of Preventive Oncology
1998-present Cancer and Leukemia Group B
2008-present American Society of Clinical Oncology
Peer Review Activities
1994-Present National Cancer Institute: Scientific Review Committee member for RFA review
1996 Center for Human Genome Research: Ad hoc Reviewer on study section: Ethical,
Legal, and Social Implications of Human Genome Research
1997-98 National Cancer Institute: Member of review committee and site visitor for
Program Project applications
1998 National Institutes of Health, Sub-Committee E/F: Ad hoc grant reviewer
1997 National Institutes of Health, Small Business Innovation Research Program:
Member of Review Committee
1999 Agency for Health Care Research and Policy: Member, Health Care Technology
and Decision Sciences Special Emphasis Panel
1999-2002 National Institutes of Health, Center of Scientific Review: Member, Social
Sciences, Nursing, Epidemiology, and Methods Study Section I
2002-present National Institutes of Health, Center of Scientific Review: Member, Sub-
4. Committee E. Cancer Control Program Projects.
2007-present National Institutes of Health, Center of Scientific Review: Health Services and
Organizational Delivery (HSOD) Study Section
1992-95 Office of Disease Prevention and Health Promotion, DHSS: Member, Panel on the
Cost-Effectiveness in Health and Medicine
1993 Major's Office, New York City Health and Hospitals Corporation: Member, "Blue
Ribbon Panel on Women's Health"
1994-1996 Member, Panel on Cost-Effectiveness in Health and Medicine, US DHHS, Office
of Disease Prevention and Health Promotion
1997 NIH/National Cancer Institute: Member, Breast Cancer Peer Review Group,
Health Outcomes Committee
1997-99 Program for the Evaluation of Medical Technologies, Advisory Board Member,
1998-2005 Cancer and Leukemia Group B: Member, Executive Committee Member, Cancer
Control and Health Outcomes Committee
1998-present Cancer and Leukemia Group B: Member, Cancer in the Elderly Working Group
1998-2004 United States Preventive Services Task Force: Senior Scientific Advisor
1998 Institute of Medicine, Nat. Cancer Policy Board: “Ensuring Quality Cancer Care"
1999-2005 Cancer and Leukemia Group B: Vice Chair, Clinical Economics and Health
Services Subcommittee of the Cancer Control and Health Outcomes Committee
2000 Cancer Outcomes Measurement Working Group. Member, NCI
2003 American Cancer Society. Cervical Cancer Screening. Elderly Working Group
2008 American Society of Clinical Oncology. Program Committee, Health Services Research
1987-present Manuscript Reviewer: Journal of the American Medical Association, Annals of
Internal Medicine, Journal of Clinical Oncology, Journal of General Internal
Medicine, Journal of the National Cancer Institute, Cancer Epidemiology
Biomarkers and Prevention, Preventive Medicine, American Journal of Preventive
Medicine, American Journal of Public Health, Medical Care and others
5. 2004-present Editorial Board, Journal of Clinical Oncology
2007-present Editorial Board, Journal of Cancer Survivorship
INVITED LECTURES (selected past subset)
Presenter, 8th Annual International Symposium on Prevention and Detection of Cancer,
International Society for Preventive Oncology, "Is HIV a Co-Factor for Cervical Cancer?" Nice,
France, March 17, 1993
Presenter, 8th Annual International Symposium on Prevention and Detection of Cancer,
International Society for Preventive Oncology, "Physician-based Interventions to Increase Breast
Cancer Screening", Nice, France, March 17, 1993
Keynote Speaker, Cancer and Leukemia Group B Spring Workshop, Cancer Control Committee,
"Breast and Cervical Cancer Screening for Minority Elderly Women", Baltimore, Maryland, May
Symposium Co-Leader, American Society of Preventive Oncology, "Use of Cost-Effectiveness
and Decision Analysis in Evaluating Cancer Services." Washington, DC, 1994
Panel Speaker, "Historical Perspectives on Cancer Outcomes Research", St. Mary's Annual
Symposium on Cancer Quality of Life, Long Beach, California, 1995
Lead Speaker, Kaiser Permanente of Northern California, "Evidence for Cervical Cancer
Screening Policies", Oakland, California, October, 1996
Faculty, American Society of Preventive Oncology, New Investigator's Workshop, Washington,
DC, March, 1998
Speaker, Agency for Health Care Policy and Research Second Annual Meeting of Study Section
Members, "Cost-Effectiveness Analysis: State of the Art, Emerging Issues, and Application",
Washington, DC October 7, 1999.
Plenary Speaker, Society of Medical Decision Making Annual Meeting, "Cost-Effectiveness of
Pap Smear Screening - A Public Policy Success", Cleveland, Ohio, September 2000
Speaker, International Human Papillomavirus Meeting, "Cost-Effectiveness of Different Cervical
Cancer Screening Strategies in Under-developed Countries", Barcelona, Spain, July 27, 2000
Plenary Speaker, Cancer and Leukemia Group B, "Breast Cancer Treatment Choices and
Outcomes in Older Women: Lessons from the Real World", New Orleans, June 9, 2000
Faculty, American Society of Preventive Oncology, New Investigator's Workshop, Washington,
DC, March 5, 2000
Panel Speaker, "Barriers to Assessing Quality Cancer Care", Ensuring Quality Cancer Care,
Robert H. Lurie Cancer Center, Chicago, Illinois, November 10, 2000
6. Lead Speaker and Workshop Leader, National Institute of Aging and National Cancer Institute,
"The Role of Cancer Centers in Leading Gero-Oncology Research - Lessons from Cancer
Control", NIA Conference on Aging and Cancer Centers, June 2001
Preparing an RO3 application. NCI, Center for Reducing Cancer Health Disparities, 2007, 2008
Preparing a Career Development Award Application. Society for Medical Decision Making, Oct
21, 2007, Oct 2008
1996-99 Research Review Committee, Division of Prevention and Control Research,
Lombardi Cancer Center
1997-00 Cancer Committee, Lombardi Cancer Center, Department of Oncology
1999-2002 Clinical Research Committee, IRB , Department of Oncology
1999 Cross-Campus Committee to Develop a Center on Aging (Maxine Weinstein,
2000-present Executive Committee, Lombardi Comprehensive Cancer Center
2000-01 Member, Search Committee for Cancer Center Director and Chair of the
Department of Oncology
Community Lectures and Service (selected)
1987-89 Chairperson, Cancer Task Force, New York City Health and Hospital Corporation
1995 Presentation on "Breast Cancer in Older Women" to AARP's Breast Care
Campaign, Healing Legacies and the Art of Hollis Sigler
1995 Presentation on "Patterns of Breast Cancer Care" to oncologists and surgeons at
1996 Presentation on "Breast Cancer Screening in Older Women" to AARP's Breast
1997 Presentation on "Breast Cancer in the Elderly" at Oncology Grand Rounds,
George Washington Medical Center
2002-2006 Chair, DC Cancer Coalition/Consortium, Cancer Control Plan
2006-present Executive Committee, DC Cancer Consortium
7. TEACHING ACTIVITIES (selected)
1981-87 Clinical Preceptor, Department of Ambulatory Care, City Hospital Center at
1984-87 Section Leader and Mentor, Community Medicine Research Clerkship,
Department of Community Medicine, Mt. Sinai School of Medicine
1984-87 Section Leader, Epidemiology and Biostatistics Core Curriculum, Department of
Community Medicine, Mt. Sinai School of Medicine
1987-89 Course Director, Research Design in Geriatric Medicine, Division of Geriatrics,
Montefiore Medical Center and Albert Einstein School of Medicine
1987-89 Section Leader, Epidemiology and Biostatistics Core Medical Student Curriculum,
Department of Epidemiology and Social Medicine, A. Einstein School of Medicine
1989-94 Course Director, Research Design in Primary Care/Critical Appraisal of the
Medical Literature, General Internal Medicine, Cornell Univ. School of Medicine
Associate Professor, Georgetown University:
1994-2001 Clinical Preceptor, Division of Primary Care, Department of Medicine,
Georgetown University Medical Center
1994-2001 Mentor, Cancer Control Program, Lombardi Cancer Center, Department of
Oncology, Georgetown University Medical Center
1996 Lecturer, Institute for Health Care Policy and Research Seminar Series
1997 Lecturer, Tumor Biology I, Department of Cell Biology
1998 Group Co-Leader, Introduction to the Patient, Georgetown University School of
1999 Lecturer, Tumor Biology I, Department of Cell Biology
1999-2002 Fellowship Director, Primary Care Research Methods, Department of Medicine,
Georgetown University School of Medicine.
Professor, Georgetown University:
2001-present Clinical Preceptor, Division of Primary Care, Department of Medicine,
Georgetown University Medical Center
2001-present Mentor, Cancer Control Program, Lombardi Comprehensive Cancer Center,
Department of Oncology, Georgetown University Medical Center
8. 2001-present Lectures in Tumor Biology Program and Cancer Control Master’s Program
Post-Doctoral Trainees (selected)
1996-98 George Sawaya, MD, NCI Mentored Clinical Scientist Development Award,
Cervical Cancer Screening in Older Women
1996-99 William Lawrence, MD, MsC, Dept. of Defense Career/IDEA Grant, Translation
of BRCA1/2 Testing into Clinical Practice
1997-2005 Ann O'Malley, MD, MPH, Dept. of Defense Career Development Award, Cancer
Screening in Multi-ethnic and Under-served Populations
1997-00 Caroline Burnett, PhD, NINR Career Development Award, Breast Cancer
Screening in Elderly Black Women
1999-present Wenchi Liang, PhD, NCI Preventive Oncology Career Development Award,
Cancer Screening in Chinese Women
NCI, RO1, Increasing Colorectal Cancer Screening by Chinese Physicians
2000-2005 Robin Yabroff, PhD, NCI Preventive Oncology Career Development Award,
Follow-up of Abnormal Cancer Screening
2001-Present Vanessa Sheppard, PhD, National Institute on Aging/National Cancer Institute,
Understanding Black Women’s Chemotherapy Decisions, Minority Investigator
Supplement, Older Women’s Chemotherapy Decisions.
Komen Foundation, A Navigator Delivered Skills Intervention to Improve
Communication and Decision-Making among African American Breast Cancer
Komen National Race For the Cure, A Comprehensive Culturally and
Linguistically Peer Approach to Navigating the DC Breast Health System.
American Cancer Society Mentored Scholar Research Grant, Closing the Gap:
Increasing Adherence to Adjuvant Therapy in Black Women.
2002-2006 Melissa Figueiredo, PhD, Komen and NCI grants, Quality of Life in Latina Breast
Cancer Survivors and NCI, Chemotherapy Decisions and Outcomes in Women
Age 65 Years or Older with Operable, Newly Diagnosed Breast Cancer
2002-Present Judy Wang, PhD, Department of Defense, Breast Cancer Career Development
Award, The Influence of Culture on Women’s Breast Cancer
Susan G. Komen Breast Cancer Foundation Special Population Research Grant,
Reducing Disparities in Breast Cancer Screening in Chinese American women
9. American Cancer Society Mentored Scholar Research Grant, Promoting
Adherence to Mammography Use in Chinese American Women
National Cancer Institute, R03 research award, Promoting Adherence to
Mammography Use in Chinese American Women
Lance Armstrong Foundation, Career Award, Chinese Breast Cancer Survivors
2007-present Maria Lopez, PhD, RO3 CNP pilot research award, Smoking Cessation in Latino
NCI supplement, Developing a scale of Latino Cultural Health Values.
2007-present Barbara Kreling, PhD, RO3 CNP pilot research award, Comparing Hospice use in
Latinos and Whites
RO3 CNP pilot research award, Barriers to Chemotherapy in Latinos Patients
ACS Palliative Care Award, Developing a LHW Intervention to Improve Latino
SCHOLARSHIP AND RESEARCH
Peer-Reviewed Grant Support - Previous
Assistant and Associate Professor, Cornell and Memorial Sloan Kettering Cancer Center:
1989-90 Principal Investigator, Old, Poor, Black: Combating Cancer Triple Jeopardy,
USDHHS NCI Grant # RO3 CA51614, $31,717
1989-92 Co-Investigator, Emergency Room Cancer Screening Program (Freeman PI),
USDHHS NCI Grant # RO1 CA50520, $630,533.
1989-94 Principal Investigator, Breast and Cervix Cancer Control in the Elderly, NIA
Grant # KO8 AG00471, $350,000.
1990-91 Principal Investigator, "Professional Education to Enhance Early Cancer
Detection in Public Hospitals", NYC American Cancer Society, $10,000.
1990-93 Co-Investigator, Cancer Control Needs in Multi-Ethnic Communities (Kerner
PI), USDHHS NCI Grant # RO1 CA53083, $257,684
1991-92 Co-Investigator, Loss of Primary Care: Health Outcomes Among the
Uninsured, United Hospital Fund, Special Projects, NY, $85,000.
1993-94 Principal Investigator, Molecular Epidemiology of Cervical Neoplasia in Older
Blacks, New York Community Trust, $100,000.
10. Associate Professor, Georgetown University:
1994-97 Co-Investigator, Cost-Effectiveness of Breast Cancer Treatment in the Elderly
(Hadley PI), Dept. of Defense, Grant # DAM17-94-J-4212, $852,136.
1994-97 Co-Investigator, Follow-up of Abnormal Mammograms in African-American
Women (Kerner PI), USDHHS, NCI, Grant # 1R01 CA62360-01, $845,308.
1994-98 Co-Principal Investigator, Care, Costs, and Outcomes of Local Breast Cancer
Treatment in the Elderly (Hadley PI), AHCPR PORT, Grant # R01 CA08395
1997-98 Principal Investigator, Care, Costs, and Outcomes of Local Breast Cancer:
Elderly African-Americans, AHCPR Supplement, Grant # R01 HS08395
1996-Jan 01 Principal Investigator, Cancer Clinical and Economic Outcomes Core, Breast
Cancer Center Grant (Lippman PI), Dept of Defense, Grant #DAMD17-96-C-
1996-Jan 01 Co-Investigator, Impact of Genetic Testing for Breast Cancer Susceptibility, Dept
of Defense (DAMD17-96-C-6069), $758,594 (PI: Lerman).
1997-June 01 Principal Investigator, The Cost-Effectiveness of HPV Screening for Cervical
Cancer in Older Women, National Institute of Aging, Grant # R01 CA74187
1997-02 Co-Investigator, Decisions and Outcomes of BRCA1/2 Testing in Newly
Diagnosed Breast Cancer Patients (R01 CA/HG74861), National Cancer Institute,
$1,921,385 (PI: Lerman/Schwartz).
1998-June 01 Principal Investigator, (Georgetown Sub-contract; M. Fahs PI), ACost-
Effectiveness Analysis of Breast Cancer Control for Older African-Americans,
National Cancer Institute, Grant # 1 R01 CA72908, $1,417,007.
1998-01 Co-Investigator, Comparing Models of Counseling for BRCA1/2 Testing
(Renewal) (2R01 HG01846), NIH/National Human Genome Research Institute,
$1,844,172 (PI: Lerman/Schwartz).
1998-Sept 01 Principal Investigator, Care, Costs, and Outcomes of Local Breast Cancer
Treatment in the Elderly, AHCPR PORT, Grant # R01 CA08395, $4,801,480.
1998-02 Co-investigator, Breast Cancer: Preparing for Survivorship,National Cancer
Institute (PI: Ganz).
1999-02 Principal Investigator, A Phase II Clinical Study of Indole-3-Carbinol vs.
Placebo for Efficacy in Human Papillomavirus (HPV) Eradication. National
11. Cancer Institute, Grant # N01 CA95138, $1,092,568.
1999-02 Co-investigator, Cohort Study of Cancer Patient Caregiver Outcomes, National
Institute of Nursing Research (Ingham).
1999-03 Principal Investigator, Institutional NRSA (Primary Care Research Methods
T32), HRSA, Grant # 6T32 PE10017, $522,276 per year.
2000-June 01 Principal Investigator, (Georgetown Sub-contract; M. Fahs PI),Towards
Optimal Screening Strategies: Upper Age Limits for Mammography Screening,
Supplement to Cost-Effectiveness Analysis of Breast Cancer Control for Older
African-Americans, National Cancer Institute, Grant # 1R01 CA72908, $67,670.
2000-02 Co-Investigator, Breast Cancer Genetic Susceptibility Testing - A Primary Care
Perspective. (PI: Lawrence) DoD, Grant # DAMD17-00-1-0268, $148,718.
2000-04 Principal Investigator, Outcomes Across the Spectrum of Breast Cancer Care
(CISNET), National Cancer Institute, Grant # 1U01 CA88283A, $755,158.
2000-05 Principal Investigator, (Georgetown Sub-Contract, E. Huerta, PI), Marketing
Cancer Control to Latin Americans, National Cancer Institute, Grant # 1U01
2001-08 Principal Investigator, Chemotherapy Decisions and Outcomes for the Elderly,
National Cancer Institute, Grant #U10 CA84131, $2,500,000.
Peer-Reviewed Grant Support – Active
Professor, Georgetown University:
National Cancer Institute (Mandelblatt) 08/16/02 – 06/30/12
2 K05 CA96940
“Cancer Control at the Intersection of Aging Research”
This grant provides career development support for cancer and aging and minority research to
develop new initiatives and mentoring.
National Cancer Institute (Weiner) 05/1/2002-4/30/09
NIH 5P30 51008
Cancer Center Support Grant
Associate Director for Population Science
National Cancer Institute (Mandelblatt) 09/01/05 - 08/31/10
12. “CISNET: Outcomes Across the Spectrum of Breast Cancer Care”
To model trends in cancer incidence and mortality by age, health, and race.
National Cancer Institute (Schwartz) 07/01/2004 –
5 R01 CA074861-08
“Decisions & Outcomes of BRCA ½ Test for Breast Patients” -- This project tests
the impact of genetic testing and counseling on treatment decisions and outcomes and tests the
cost-effectiveness of different treatment options for women with mutations.
National Cancer Institute (Mandelblatt/Huerta) 04/01/05 – 3/31/10
5 U01 CA114593-02
“Latin American Cancer Research Coalition”
To approve cancer outcomes and underserved Hispanic populations.
Department of Defense (Mandelblatt/Neugut) 03/01/05 – 2/28/10
“Racial Disparities in the Initiation and Intensity of Adjuvant Therapy in Breast Cancer”
To improve cancer outcomes and underserved Black populations.
National Cancer Institute (Mandelblatt/ Patierno) 09/29/05- 08/31/2010*
“DC Patient Navigation Project”
To test the effectiveness and cost-effectiveness of patient navigation
*transferred to Eng-Wong in Nov 2008
National Cancer Institute (Mandelblatt) 07/01/07 – 06/30/12
“Developing an Index of Physiological Age”
To develop a predictive index for chemotherapy toxicity in older women
National Cancer Institute (Mandelblatt)
2R01CA127617 (continuation of U10 CA84131) 04/01/08-03/31/15
“Who Cares for Elderly Cancer Survivors and Does it Matter for Quality”
To describe the types of physicians who care for survivors and test how specialty affects quality
of care, satisfaction and quality of life.
National Cancer Institute (Co-investigator, PI: Graham) 04/01/08– 3/31/109
“Using the Internet to Reach Latino Smokers for Cessation”
American Cancer Society (Mandelblatt, Kreling) 03/01/08-02/28/10
“End of Life Care in Latinos”
National Cancer Institute 12/01/2008 –
“Older Breast Cancer Patients: Risk for Cognitive Decline
National Cancer Institute
1R01CA129142 (PI: Kinney, co-investigator: Mandelblatt) 7/01/2009 –
“Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women”
Instructor and Assistant Professor, Mt. Sinai School of Medicine:
1. Mandelblatt JS, Hammond DB. Gynecological Care of Elderly Women: Is Papanicolaou
Smear Testing Necessary? Mt Sinai J Med 1985;52:284-290.
2. Mandelblatt JS, Skovron ML, Gopaul I. Papanicolaou Smear Screening and the Elderly.
3. Mandelblatt JS, Gopaul I, Wistreich M. Gynecological Care of Elderly Women in a
Primary Care Setting: Another Look at Papanicolaou Smear Testing. JAMA 1986;256:367-
4. Mandelblatt JS, Gopaul I, Wistreich M. Papanicolaou Smear Testing in Elderly Women.
5. Ziffer A, Song P, Mandelblatt JS. Preventive Health Practices in a Teaching Hospital:
Housestaff Performance of Gyn Screening. Amer J of Prev Med 1987;3(3):142-146.
6. Mandelblatt JS, Adler RA, Bennett NM, Fein OT, et al. Ambulatory Care Activities and
Responses to Cost Containment. J of Gen Med 1987;2:388-393.
Assistant Professor, A. Einstein School of Medicine:
7. Mandelblatt JS, Fahs M. Cost Effectiveness of Cervical Cancer Screening for Elderly Low
Income Women. JAMA 1988;259:2409-2413.
8. Tarr D, Palacio H, Mandelblatt JS. The Role of Primary Care Physicians in Pap Smear
Screening of Elderly Women. NYS J Med 1988;88:296-299.
9. Wheat ME, Mandelblatt JS. Pap Smear Screening in Women 65 and Over. J Amer
Geriatrics Soc 1988;36:827-830.
10. Mandelblatt J. Cervical cancer screening in primary care: issues and recommendations. Prim
Care. 1989 Mar;16(1):133-55.
14. Assistant and Associate Professor, Cornell and Memorial Sloan Kettering Cancer Center:
11. Mandelblatt J, Schechter C, Fahs M, Muller, C. Clinical implications of screening for
cervical cancer under Medicare: The natural history of cervical cancer in the elderly: What
do we know? What do we need to know? Amer J Obstet and Gynecol 1991;164:644-51.
12. Mandelblatt JS, Andrews H, Kerner JF, Zauber A, Burnett W. Determinants of late stage
diagnosis of breast and cervical cancer. AJPH 1991;81:646-649.
13. Mandelblatt JS. Papanicolaou testing after hysterectomy. JAMA 1991; 266: 1289.
14. Mandelblatt J, Fahs M, Garibaldi K, Senie R, Peterson H. The association between human
immunodeficiency virus infection and cervical neoplasia. AIDS 1992;6:173-178.
15. Mandelblatt JS, Wheat ME, Monane M, Moshief R, Hollenberg J, Tang J. Breast cancer
screening for elderly women with and without co-morbid conditions: a decision model.
Annals of Internal Medicine 1992;116:722-730.
16. Mandelblatt JS, Richard R, Thomas L, Chauhan P, Traxler M, Lakin P, et al. Is HPV
associated with cervical neoplasia in the elderly? Gynecologic Oncology 1992;46:6-12.
17. Fahs M, Mandelblatt J, Schechter C, Muller C. The costs and effectiveness of cervical
cancer screening in the elderly. Annals of Internal Medicine 1992;117:520-527.
18. Kanetsky P, Mandelblatt J, Richard R, Gammon M. Risk factors for cervical cancer in
black, elderly women. Ethnicity and Disease 1992;2:337-342.
19. Mandelblatt JS, Traxler M, Lakin P, Kanetsky P, Kao R. Mammography and
Papanicolaou smear use by elderly poor black women. JAGS 1992;40:1001-1007.
20. Mandelblatt J, Traxler M, Lakin P, Thomas L, Chauhan P, Matseoane S, Kanetsky P. A
nurse practitioner intervention to increase breast and cervical cancer screening for elderly,
poor, black women. J of Gen Intern Med 1993;8:173-178.
21. Mandelblatt J. Squamous cell cancer of the cervix, immune senescence and HPV: is cervical
cancer an age-related neoplasm? Adv Exp Med Biol. 1993;330:13-26. Review.
22. Mandelblatt J, Traxler M, Lakin P, Kanetsky P, Kao R. Targeting breast and cervical
cancer screening to elderly poor black women: Who will participate? Prev Med
23. Kerner JF, Dusenbury L, Mandelblatt JS. Poverty and Cultural Diversity: Challenges for
Health Promotion among the Medically Under served. Ann Rev of PH 1993;14:355-377.
24. Andrews H, Kerner JF, Zauber A, Mandelblatt J, Pittman J, Struening E. Using census
and mortality data to target small areas for breast, cervix and colorectal cancer screening.
AJPH 1993; 84:56-61.
25. Mandelblatt J, Traxler M, Thomas L, Chauhan P, Kanetsky P, Lakin P, Matseoane S,
15. Breast and cervical cancer screening of poor, elderly, black women. Amer J Prev Med
26. Kurman RJ, Henson DE, Herbst AL, et al and the NCI Workshop (Mandelblatt JS,
participant). Guidelines for Management of Abnormal Cervical Cytology. JAMA
Associate Professor, Georgetown University:
27. Mandelblatt JS, Kanetsky PA. Effectiveness of interventions to enhance physician
screening for breast cancer. J of Family Practice 1995;40:162-171.
28. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Impact of Access and Social
Context on Breast Stage at Diagnosis. J of Health Care for the Poor and Underserved
29. Rojas M, Mandelblatt J, Cagney K, Kerner JF, Freeman H. Barriers to Follow-Up of
Abnormal Mammograms among Low Income Minority Women. Ethnicity and Health
30. Fahs MC, Plichta SB, Mandelblatt JS. Cost-Effective Policies for Cervical Cancer
Screening. PharmacoEconomics 1996;9(3):211-230.
31. Mandelblatt JS, Eisenberg JM. Historical and Methodological Perspectives on Cancer
Outcomes Research. Oncology 1996;9:23-32.
32. Russell L, for members of the Panel on Cost-Effectiveness in Health and Medicine
(Mandelblatt, panel member). The Role of Cost-Effectiveness Analysis for Decision
Making in Health. JAMA 1996;276:1172-1177.
33. Weinstein M, for members of the Panel on Cost-Effectiveness in Health and Medicine.
Recommendations for Conducting Cost-Effectiveness Analysis (Mandelblatt, panel
member). JAMA 1996;276:1253-1258.
34. Seigel J, for members of the Panel on Cost-Effectiveness in Health and Medicine
(Mandelblatt, panel member). Reporting the Results of Cost-Effectiveness Analysis.
35. Mandelblatt JS, Phillips R. Cervical Cancer - How Often and Why - to Screen Older
Women. Geriatrics 1996;51:45-48.
36. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Late Stage Diagnosis of
Colorectal Cancer: The Relationships Between Poverty, Race, Gender, Age, and Settings of
Care. AJPH 1996;86:1794-1797.
37. Mandelblatt, J, Freeman H, Williams S, Trowers R, Cagney K, Winczewski D, Kerner J.
The Implementation of breast and cervical cancer screening in a public hospital emergency
16. room. Annals of Emergency Med 1996;28:493-498.
38. Mandelblatt JS, Freeman H, Winczewski D, Cagney K, Kerner JF. The costs and yields of
emergency room screening for breast and cervix cancer. Amer J Public Health
39. O’Malley A, Mandelblatt J, Kerner J, Gold K, et al. Primary Care in Breast and Cervix
Cancer Screening Among Multi-Ethnic Populations. Arch Int Med 1997;157:1462-1470.
40. Mandelblatt J, Fryback D, Weinstein M, Gold M, Russell L, Hadorn D, and members of
the Panel on Cost-Effectiveness in Health and Medicine. Assessing the Effectiveness of
Health Interventions. J Gen Intern Med 1997;12:551-558.
41. Taylor KL, Kerner JF, Gold KF, Mandelblatt JS. Ever vs Never Smoking Among an
Urban, Multiethnic Sample of Haitian-, Caribbean-, and US-born Blacks. Preventive
42. Kanetsky PA, Gammon M, Mandelblatt JS et al. Cigarette Smoking and Cervical
Dysplasia Among non-Hispanic Black Women. Cancer Detection and Prevention
43. Lawrence W, Liang, W, Mandelblatt, J, et al. Serendipitous MRI Lesions. JNCI
44. Kanetsky PA, Gammon M, Mandelblatt JS et al. Dietary Intake and Blood Levels of
Lycopene: Association with Cervical Dysplasia Among non-Hispanic Black Women.,
Nutrition and Cancer, 1998 31(1):31-40.
45. O’Malley AS, Kerner JF, Johnson A, Mandelblatt JS. Acculturation and Breast Cancer
Screening Among Hispanic Women in New York City. American Journal of Public Health,
46. Mandelblatt J, O’Malley A, Gold K, Kerner J. Breast and Cervix Cancer Screening Use
Among Multi-Ethnic Women: Role of Age, Health, and Source of Care. Prev Med
47. Mandelblatt JS, Kanetsky PA, Eggert, L, Gold K. Is HIV Infection a Co-factor for
Cervical Squamous Cell Neoplasia? Cancer Epidemiology, Biomarkers, and Prevention
48. Mandelblatt J, Ganz P, Kahn K. A Proposed Agenda for the Measurement of Breast
Cancer Quality of Care in Oncology Practice. J Clin Oncol 1999;17(8):2614-2622.
49. Mandelblatt J and Yabroff RK. Effectiveness of Interventions Designed to Increase
Mammography Use: A Meta-Analysis of Provider-targeted Strategies. CA Epi Biomarkers
17. 50. Yabroff RK and Mandelblatt J. Interventions Targeted toward Patients to Increase
Mammography Use. CA Epi Biomarkers Prev 1999;8:749-757.
51. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable Access to Cancer Services: A Review
of Barriers to Quality Care. Cancer 1999;86:2378-90.
52. Mandelblatt JS, Yabroff KR. Breast and Cervical Cancer Screening in the Elderly:
Recommendations and Challenges for the 21st Century. JAMWA, 2000; 55:210-5.
53. Mandelblatt J, Yabroff KR, Lawrence W, Yi B, Orosz G, Bloom HG, Schecther CB, et al.
Screening Mammography in the Elderly. Research on Breast Cancer in Older Women
Consortium. JAMA, 2000; 283, 3202-3.
54. Mandelblatt J, Hadley J, Kerner J, Schulman K, et al. Patterns of Breast Carcinoma
Treatment in Older Women: Patient Preference, Clinical, and Physician Influences. Cancer,
55. Yabroff R, Mandelblatt J, Kerner J. Effectiveness of Interventions to Improve Follow-up
After Abnormal Cervical Cancer Screening. Prev Med, 2000: 31(4) 429-439.
56. Padgett D, Yedidia M, Kerner J, Mandelblatt J. The Emotional Consequences of False
Positive Mammography: African-American Women’s Reactions in Their Own Words.
Women’s Health, 2000: 33(3-4) 1-14.
57. Sawaya GF, Grady, D, Kerlikowske K, La Valleur J, Barnabei VM, Bass K, Snyder TE,
Pickar JH, Agarwal S, Mandelblatt J. The Positive Predictive Value of Cervical Smears in
Previously Screened Post-menopausal Women: The Heart and Estrogen/progesterone
Replacement Study (HERS). Annals of Internal Medicine 2000;133:942-950.
58. Lawrence W, Mandelblatt J, Liang W, Peshkin B, Lerman C. The Costs of Genetic
Counseling and Testing for BRCA1/2 Mutations. Ca Epi Biomarkers Prev, 2001: 10(5)
59. Mandelblatt JS, Bierman AS, Gold K, Zhang Y, Ng J, Maserejan N, Meropol N, Hadley J,
Silliman R. Constructs of Burden of Illness in Older Breast Cancer Patients: A Comparison
of Measurement Methods. Health Svc Res 2001:36(6 pt 1) 1085-1107.
60. Mandelblatt JS, Berg CD, Meropol NJ, Edge SB, Gold K, Hwang YT, Hadley J.
Measuring and Predicting Surgeons: Practice Styles for Breast Cancer Treatment in Older
Women. Medical Care 2001: 39(3) 228-242.
61. Hadley J, Mandelblatt J, Mitchell J, et al. Medicare Fees and Small Area Variations in
Breast Conserving Surgery Among Elderly Women. Medical Care Research and Review,
62. Saha S, Hoerger TJ, Pignone M, Teutsch SM, Helfand M, Mandelblatt JS. The Art and
Science of Incorporating Cost-Effectiveness into Evidence-based Recommendations for
Clinical Preventive Services. Amer J Prev Med, 2001:20(3 Suppl):36-43.
18. 63. Sawaya G, Grady, D, Kerlikowske K, Hiatt R, Mandelblatt J. Advancing Age and
Cervical Cancer Screening and Prognosis. JAGS, 2001:49(11) 1499-504.
64. Hagen MD, Garber A, Goldie SJ, Lafata J, Mandelblatt J, Melter D, Neumann P, Sox H,
Tsevat J. Does Cost-Effectiveness Analysis Make a Difference? Lessons from Pap Smears.
Med Decis Making, 2001;21(4):307-23.
65. Kerner JF, Mandelblatt JS, Silliman RA, Lynch JJ, Senie R, Cohen C, Hwang YT;
OPTIONS Research Team. Outcomes and preferences for treatment in older women
nationwide study. Screening mammography and breast cancer treatment patterns in older
women. Breast Cancer Res Treat. 2001 Sep;69(1):81-91
66. Yabroff K, O'Malley A, Mangan P, Mandelblatt J. Inreach and Outreach Interventions to
Improve Mammagraphy Use. JAMWA 2001:56(4):166-174.
67. O’Malley AS, Lawrence W, Liang W, Lynn J, Kerner J, Mandelblatt J. Feasibility of
Mobile Cancer Screening and Prevention. J Health Care Poor Underserved,
68. Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM Jr, Hwang
YT, Mandelblatt JS. Patient and provider characteristics that affect the use of axillary
dissection in older women with stage I-II breast carcinoma. Cancer. 2002 15;94(10):2534-
69. Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, et al. Sequelae of
axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer.
2002 Dec 15;95(12):2445-54.
70. Mandelblatt, J., Lawrence, W., Gaffiken, L., and et al. Cost and benefits of alternative
cervical cancer screening programs in less developed countries. Journal of the National
Cancer Institute. 2002: 94(19): 1469-1483.
71. Mandelbaltt JS, Lawrence WF, Womack SM, Jacobson D, Hwang YT, Gold, K, Barter J,
Shah K. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA
287(18): 2372-81, 2002.
72. Mandelblatt JS, Kerner JF, Hadley J, Hwang YT, Eggert L, Johnson LE, et al. Variations
in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer.
2002 Oct 1;95(7):1401-14.
73. Klassen AC, Smith AL, Meissner HI, Zabora J, Curbow B, Mandeblatt J. If we gave away
mammograms, who would get them? A neighborhood evaluation of a no-cost breast cancer
screening program. Prev Med.2002;34(1):13-21.
74. Liang W, Burnett CB, Rowland JH, Meropol NJ, Eggert L, Hwang YT, Silliman RA,
Weeks JC, Mandelblatt JS. Communication between physicians and older women with
localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol.
75. O'Malley AS, Renteria-Weitzman R, Huerta EE, Mandelblatt J. Patient and provider
priorities for cancer prevention and control: a qualitative study in Mid-Atlantic Latinos.
Ethn Dis. 2002 Summer;12(3):383-91.
76. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal
cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann
Intern Med. 2002 Jul 16;137(2):96-104. Review. Summary for patients in: Ann Intern Med.
2002 Jul 16;137(2):I38.
77. O'Malley, A. S., Forrest, C. B., and Mandelblatt, J. Adherence of low-income women to
cancer screening recommendations. J.Gen.Intern.Med., 17: 144-154, 2002.
78. Saslow D, Runowicz CD*, Solomon D, Moscicki B, Smith RA, Eyre HJ, Cohen C. *
Mandelblatt J, member of Work Group on Interval, OlderWomen, and Hysterectomy.
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and
Cancer. CA Cancer J Clin, Nov 2002; 52: 342 - 362.
79. Hadley, J., Mandelblatt, J., Mitchell, J., Weeks, J. C., Guadagnoli, E, and Wang, Q.
Medicare Breast Surgery Fees and Treatment Received by Older Women with Localized
Breast Cancer. Health Serv Res. 2003 Apr;38(2):553-73.
80. O'Malley AS, Mandelblatt J. Delivery of preventive services for low-income persons over
age 50: a comparison of community health clinics to private doctors' offices.J Community
Health. 2003 Jun;28(3):185-97.
81. Polsky D, Mandelblatt JS, Weeks JC, Venditti L, Hwang YT, Glick HA. Economic
evaluation of breast cancer treatment: considering the value of patient choice. J Clin Oncol.
2003 Mar 15;21(6):1139-46.
82. Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, et al. Predictors of
long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J
Clin Oncol. 2003 Mar 1;21(5):855-63.
83. Hadley J, Polsky D, Mandelblatt JS, Mitchell JM, Weeks JC, Wang Q, et al. An
exploratory instrumental variable analysis of the outcomes of localized breast cancer
treatments in a Medicare population. Health Econ. 2003 Mar;12(3):171-86.
84. Mandelblatt J, Figueiredo M, Cullen J. Outcomes and quality of life following breast
cancer treatment in older women: When, why, how much, and what do women want?
Health and Quality of Life Outcomes 2003, 1:45 (17 Sep 2003).
85. O'Malley AS, Gonzalez R, Sheppard V, Huerta E, Mandelblatt J. Primary care cancer
control interventions that include Latinos. Am J Prev Med,. 2003 Oct;25(3):264-71.
86. Yabroff KR, Mangan T, Mandelblatt J. Effectiveness of interventions to increase
Papanicolaou smear use. J Am Board Fam Pract. 2003 May-Jun;16(3):188-203.
20. 87. Kerner J; Yedidia M; Padgett D, Muth B; Washington K; Tefft M, Mandelblatt J, et
al. Realizing the promise of breast cancer screening: Clinical follow-up after abnormal
screening among Black Women. Prev Med. 2003 Aug;37(2):92-101.
88. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M; Cost
Work Group of the U.S. Preventive Services Task Force. The cost-effectiveness of
screening mammography beyond age 65 years: a systematic review for the U.S. Preventive
Services Task Force. Ann Intern Med. 2003 Nov 18;139(10):835-42.
89. Cantor SB, Fahs MC, Mandelblatt JS, Myers E, Sanders G. Decision science and cervical
cancer. Cancer. 2003 Nov 1; 98(9 Suppl): 2003-8.
90. Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of
cancer-screening programs being compromised? Quality of follow-up care after abnormal
screening results. Med Care Res Rev. 2003 Sep; 60(3): 294-331.
91. Liang W, WF, Burnett CB, Hwang YT, Freedman M, Trock BJ, Mandelblatt JS, Lippman
ME. Acceptability of diagnostic tests for breast cancer. Breast Cancer Res Treat. 2003 May;
92. Smith RA, Saslow D, Sawyer KA, Burke W(for the High-Risk Work Group), Costanza ME
(for The Screening Older Women Work Group*), Evans P (for The Mammography Work
Group), Foster RS (for The Physical Examination Work Group), Hendrick E (for the New
Technologies Work Group), Eyre HJ, Sener S (for The Breast Cancer Advisory Group).
*Mandelblatt J, member of The Screening Older Women Work Group. American Cancer
Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 2003;
93. Mandelblatt J. Diagnostic Hurdle. AHRQ WebM&M. February 2004. Available at:
http://webmm.ahrq.gov/cases.aspx?ic=48. Accessed March 10, 2004.
94. Mandelblatt J., Schechter C.B., Yabroff, R.K., Lawrence W., Dignam J., Muennig P.,
Chavez Y., Cullen J., Fahs M. Benefits and Costs of Interventions to Improve Breast
Cancer Outcomes In African-American Women. Journal of Clinical Oncology, 2004; 22:
95. Mandelblatt J, Armetta C, Yabroff KR, Liang W, Lawrence W. Descriptive review of the
literature on breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst Monogr. 2004;
96. Mandelblatt J, Lawrence W, Yi B, King J. The balance of harms, benefits, and costs of
screening for cervical cancer in older women: the case for continued screening. Arch Intern
Med. 2004 Feb 9;164(3):245-7.
97. Cullen J., Schwartz M.D., Lawrence W.F., Selby J.V., Mandelblatt J.S. Short-term
impact of cancer prevention and screening activities on quality-of-life. Journal of Clinical
Oncology, 2004; 22: 943-952.
21. 98. Figueiredo, M.I., Cullen, J., Hwang Y-T, Rowland J.H., Mandelblatt J.S. Breast cancer
treatment in older women: Does getting what you want improve your long-term body
image and mental health? Journal of Clinical Oncology, 2004; 22 (19): 4002-4009.
99. Liang W, Yuan EH, Mandelblatt JS, Pasick RJ. How Chinese women view health and
cancer screening? Results from focus groups and implications for intervention. Ethnicity
and Health, 2004, 9(3):283-04.
100. O’Malley AS, Beaton E, Yabroff R, Abramson R, Mandelblatt J. Patient and Provider
Barriers to Colorectal Cancer Screening in Safety-Net Primary Care. Prev Med.
101. O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J. The role of trust in use of
preventive services among low-income African-American women. Prev Med. 2004
102. Yabroff KR, Mandelblatt JS, Ingham J. The quality of medical care at the end-of-life in
the USA: existing barriers and examples of process and outcome measures. Palliat Med.
103. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS,
Yakovlev AY, Habbema JD, Feuer EJ; Cancer Intervention and Surveillance Modeling
Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality
from breast cancer. N Engl J Med. 2005 Oct 27;353(17):1784-92.
104. Kimmick GG, Peterson BL, Kornblith AB, Mandelblatt J, Johnson JL, Wheeler J, Heinze
R, Cohen HJ, Muss HB. Improving accrual of older persons to cancer treatment trials: a
randomized trial comparing an educational intervention with standard information: CALGB
360001. J Clin Oncol. 2005 Apr 1;23(10):2201-7.
105. Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Extermann M, Fox
S, Orosz G, Silliman R, Cullen J, Balducci L; Breast Cancer in Older Women Research
Consortium. Toward optimal screening strategies for older women. J Gen Intern Med.
106. Pignone M, Saha S, Hoerger T, Lohr KN, Teutsch S, Mandelblatt J. Challenges in
systematic reviews of economic analyses. Ann Intern Med. 2005 Jun 21;142(12 Pt
107. Sheppard VB, Cox LS, Kanamori MJ, Canar J, Rodriguez Y, Goodman M, Pomeroy J,
Mandelblatt J, Huerta EE and LACRC. If you build it, they will come: methods for
recruiting Latinos into cancer research. J Gen Intern Med. 2005 May;20(5):444-7.
108. Yabroff KR, Lawrence WF, King JC, Mangan P, Washington KS, Yi B, Kerner JF,
Mandelblatt JS. Geographic disparities in cervical cancer mortality: what are the roles of
risk factor prevalence, screening, and use of recommended treatment? J Rural Health. 2005
22. 109. Mandelblatt J, Kaufman E, Sheppard VB, et al. Breast cancer prevention in community
clinics: will Latina patients participate in clinical trials? Prev Med. 2005; 40(6):611-8.
110. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in
colorectal cancer screening among Medicare beneficiaries. Arch Intern Med.
111. Tallarico M, Figueiredo M, Goodman M, Kreling B, Mandelblatt J. Psychosocial
determinants and outcomes of chemotherapy in older women with breast cancer: what do
we know? What do we need to know? Cancer J. 2005 Nov-Dec;11(6):518-28.
112. Wang JH, Liang W, Chen MY, Cullen J, Feng S, Yi B, Schwartz MD, Mandelblatt JS.
Influence of culture and cancer worry on colorectal cancer screening in older Chinese
American women. Ethnicity and Disease, 2006:16(2): 404-411.
113. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M,
Solomon D, Goldie SJ; ALTS Group. Cost-effectiveness analysis based on the atypical
squamous cells of undetermined significance/low-grade squamous intraepithelial lesion
Triage Study (ALTS). J Natl Cancer Inst. 2006 Jan 18;98(2):92-100.
114. Mandelblatt JS, Lawrence WF, Cullen J, Stanton AL, Krupnick JL, Kwan L, Ganz PA.
Patterns of care in early-stage breast cancer survivors in the first year after cessation of
active treatment. J Clin Oncol. 2006 Jan 1;24(1):77-84.
115. Kreling B, Figueiredo M, Sheppard V, Mandelblatt J. A qualitative study of factors
affecting chemotherapy use in older women with breast cancer: barriers, promoters, and
implications for intervention. Psychooncology. 2006 Apr 6. 2006 Dec;15(12):1065-76.
116. Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J. The SPECTRUM population
model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to
2000: principles and practice of the model methods. J Natl Cancer Inst Monogr. 2006;
117. Hillner BE, Mandelblatt J. Caring for older women with breast cancer: can observational
research fill the clinical trial gap? J Natl Cancer Inst. 2006 May 17;98(10):660-1.
118. Liang W, Kasman D, Wang JH, Yuan EH, Mandelblatt JS. Communication between older
women and physicians: Preliminary implications for satisfaction and intention to have
mammography. Patient Educ Couns. 2006 Dec;64(1-3):387-92. Epub 2006 Jul 26.
119. Kreling B, Canar J, Catipon E, Mandelblatt J, et al. Latin American Cancer Research
Coalition: A Community Primary Care-Academic Partnership Model for Cancer Control.
Cancer. 2006 Oct 15;107(8 Suppl):2015-22.
120. Mandelblatt J. Treating breast cancer: the age old dilemma of old age. J Clin Oncol. 2006
23. 121. Mandelblatt J, Kreling B, Figeuriedo M, Feng S. What is the impact of shared decision
making on treatment and outcomes for older women with breast cancer? J Clin Oncol. 2006
122. Mandelblatt J. To screen or not to screen older women for breast cancer: A new twist on
an old question or will we ever invest in getting the answers? J Clin Oncol. 2007 Jul
123. Wang JH, Liang W, Schwartz, M. D., Lee MM, Kreling, B., and Mandelblatt JS.
Evaluation of the impact of a culturally-tailored educational video on changes in breast
cancer-related behavior in Chinese women. Health Educ Behav 2007, 2007 Jun 29; [Epub
ahead of print].
124. Sheppard VB, Figueiredo M, Canar J, Goodman M, Caicedo L, Kaufman A, Norling G,
Mandelblatt J. Latina a Latina(SM): developing a breast cancer decision support
intervention. Psychooncology. 2008 Apr;17(4):383-91.
125. Mandelblatt JS, Cullen J, Lawrence WF, Stanton AL, Yi B, Kwan L, Ganz PA. Economic
evaluation alongside a clinical trial of psycho-educational interventions to improve
adjustment to survivorship among patients with breast cancer. J Clin Oncol. 2008 Apr
126. Liang W, Chen MY, Ma GX, Mandelblatt JS. Knowledge, perceptions, and
communication about colorectal cancer screening among Chinese American primary care
physicians. Clinical Medicine: Gastroenterology, 2008; 1:21-26.
127. Liang W, Wang J H, Chen MY, Feng S, Yi B, Lee MM, Schwartz MD, Pasick RJ,
Mandelblatt JS. Developing and validating a measure of Chinese cultural views of health
and cancer. Health Education and Behavior 2008 Jun;35(3):361-75.
128. Wang JH, Sheppard VB, Schwartz MD, Liang W, Mandelblatt JS. Disparities in cervical
cancer screening between Asian and White women. Cancer Epidemiology Biomakers &
Prevention. 2008 Aug;17(8):1968-73.
129. Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, Mandelblatt JS,
Paskett ED, Raich PC; Patient Navigation Research Program. Patient navigation: state of
the art or is it science? Cancer. 2008 Oct 15;113(8):1999-2010.
130. Mandelblatt JS, Silliman R. Hanging in the Balance: Making Decisions About the
Benefits and Harms of Breast Cancer Screening Among the Oldest Old Without a Safety
Net of Scientific Evidence. J Clin Oncol. 2009 27: 487-490.
131. Sheppard VB, Wang J, Yi B, Harrison TM, Feng S, Huerta EE, Mandelblatt JS; Latin
American Cancer Research Coalition. Are health-care relationships important for
mammography adherence in Latinas?J Gen Intern Med. 2008 Dec;23(12):2024-30.
132. Graves KD, Huerta E, Cullen J, Kaufman E, Sheppard V, Luta G, Isaacs C, Schwartz MD,
Mandelblatt J. Perceived risk of breast cancer among Latinas attending community clinics:
24. risk comprehension and relationship with mammography adherence. Cancer Causes Control.
133. Mandelblatt JS, Potosky AL. On the road to improving the quality of breast cancer care: a
distance still to travel. Med Care. 2008 Aug;46(8):759-61
134. Sheppard VB, Williams KP, Harrison TM, Jennings Y, Lucas W, Stephen J, Robinson D,
Mandelblatt JS, Taylor KL. Development of decision-support intervention for Black
women with breast cancer. Psychooncology. 2009 Mar 6.
135. Liang W, Wang J, Chen MY, Feng S, Yi B, Mandelblatt JS. Cultural Views, Language
Ability, and Mammography Use in Chinese American Women. Health Educ Behav. 2009
Feb 20. [Epub ahead of print]
136. Liang W, Wang JH, Chen MY, Mandelblatt JS. Language use and the receipt of cancer
screening recommendations by immigrant Chinese American women. J Womens Health.
137. Ramsey S, Whitley E, Mears VM, McKoy JM, Everhart RM, Caswell RJ, Fiscella K, Hurd
TC, Battalgia T, Mandelblatt J, For the PNRP. Evaluating the Cost Effectiveness of
Cancer Patient Navigation: Conceptual and Practical Issues. Cancer. 2009, in press.
138. Mandelblatt JS, Cronin K, Bailey S, et al. CISNET Breast Working Group. Effects of
mammography screening under different screening schedules: model estimates of poteitnal
benefits and harms. Annals Int Med 2009, in press.
BOOK CHAPTERS (selected)
Mandelblatt J. Cervical Cancer Screening. In: Primary Care Clinics of North America. Cancer
Prevention. Ed: R Burack. WB Saunders, Phil, Pa. March 1989 (pp 133-155).
Fahs M, Mandelblatt J. Cost-Effectiveness of Cervical Cancer Screening Among Elderly Low
Income Women. In: Preventing Disease. Beyond the Rhetoric. Eds: Richard Goldbloom and
Robert Lawrence, Springer Verlag, NY, 1990 (pp 441-446).
Muller CM, Mandelblatt J, Schechter C. The Costs and Effectiveness of Screening for Cervical
Cancer in Elderly Women. A Paper in the OTA's Series on Preventive Services Under Medicare.
Health Program, Office of Technology Assessment, U.S. Congress, Washington, DC, Feb 1990.
Mandelblatt, JS. Immune Senescence, HPV and Cervical Cancer In: Yang S, Warner H, eds.
Underlying Molecular, Cellular, and Immunological Factors in Age-Related Neoplasms. Plenum
Press, New York, 1993 (pp 13-26).
Mandelblatt JS. Breast and Cervical Cancer Screening in Elderly Poor Women. In: Oncology:
Principles and Practice. Cancer Prevention Update. Eds: DeVita, Hellman, and Rosenberg. JB
Lippincott, Phil, Pa, 1994, pages 1-7.
Mandelblatt J, Fryback D, Weinstein M, Gold M, Russell L, Hadorn D, and members of the
25. Panel on Cost-Effectiveness in Health and Medicine. Assessing the Effectiveness of Health
Interventions. In: Cost-Effectiveness in Health and Medicine. Editors: Gold M, Seigel J, Russell
L, and Weinstein M. Oxford University Press, New York, 1996 (pp 135-175).
Russell L, Seigel J, Daniels N, Luce B, Mandelblatt J, and members of the Panel on Cost-
Effectiveness in Health and Medicine. Cost-Effectiveness Analysis for Decision Making in
Health: Roles and Limitations. Editors: Gold M, Seigel J, Russell L, and Weinstein M. Oxford
University Press, New York, 1996 (pp 3-24).
Kerner JF, Trock B, Mandelblatt JS. Breast Cancer in Minority Women. In: Harris and
Lippman M, ed. Breast Diseases, 2nd Edition; 1999, pgs 955-66.
Mandelblatt J, Selby J. Outcomes for Preventive Care. In: Cancer Outcomes Measurement
Working Group. Gotay and Lipscomb, editors. Oxford Univ Press, 2003.
Kerner JF, Trock B, Mandelblatt JS. Breast Cancer in Minority Women. In: Harris and
Lippman M, ed. Breast Diseases, 3rd Edition. 2004.
Mandelblatt JS, Liang W, Sheppard V, Wang J, Isaacs C. Breast Cancer in Minority Women.
In: Harris and Lippman M, ed. Breast Diseases, 4th Edition. 2008.
Available upon request